NDC 71872-7324-01 - Cleocin Phosphate
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 71872-7324
- Requested NDC
- 71872-7324-01
- Package NDCs from labels
- 71872-7324-1, 71872-7324-01
- Manufacturer
- Medical Purchasing Solutions, LLC
- Effective date
- 2024-03-05
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| Cleocin Phosphate - Medical Purchasing Solutions, LLC | Medical Purchasing Solutions, LLC | 2024-03-05 | HUMAN PRESCRIPTION DRUG LABEL |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 71872-7324-1 | Cleocin Phosphate | 2 mL in 1 VIAL | INJECTION, SOLUTION | 2 | 1 | |
| 71872-7324-1 | Cleocin Phosphate | 1 in 1 BAG | INJECTION, SOLUTION | 1 | 1 |
DailyMed Dashboard NDC Coverage#
| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|---|---|---|---|
| 71872-7324 | CLEOCIN PHOSPHATE (CLINDAMYCIN PHOSPHATE) INJECTION, SOLUTION [MEDICAL PURCHASING SOLUTIONS, LLC] | 1 | Current NDC, 2 package rows | 20240307_12ee0720-9979-3162-e063-6394a90a8003.zip |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| clindamycin phosphate | CLINDAMYCIN PHOSPHATE | E. Fougera & Co. a division of Fougera Pharmaceuticals, LLC | 62a2019f-7410-4251-95ed-181925ade6e4 | 2026-01-28 | Warnings, Adverse reactions | EH6D7113I8 |
| Clindamycin Phosphate | CLINDAMYCIN PHOSPHATE | Sun Pharmaceutical Industries, Inc. | 80c40d1a-2541-4164-8ccb-1b512a851734 | 2026-01-25 | Warnings, Adverse reactions | EH6D7113I8 |
| Clindamycin Phosphate | CLINDAMYCIN PHOSPHATE | Viona Pharmaceuticals Inc | 585e8b72-b350-451f-a232-199b1a01e8ce | 2026-01-07 | Warnings, Adverse reactions | EH6D7113I8 |
| Clindamycin Phosphate | CLINDAMYCIN PHOSPHATE | Encube Ethicals, Inc. | ba6ae5da-affa-422b-9a53-28f3fc001523 | 2026-01-06 | Warnings, Adverse reactions | EH6D7113I8 |
| Clindamycin Phosphate | CLINDAMYCIN PHOSPHATE TOPICAL | Carnegie Pharmaceuticals, LLC | c8fe61f1-f3c5-4452-9980-a727461b9844 | 2025-12-15 | Warnings, Adverse reactions | EH6D7113I8 |
| clindamycin phosphate | CLINDAMYCIN PHOSPHATE | Mylan Pharmaceuticals Inc. | f7480256-8b32-419a-8983-e2c413040dba | 2025-12-12 | Warnings, Adverse reactions | EH6D7113I8 |
| CLINDAMYCIN PHOSPHATE | CLINDAMYCIN PHOSPHATE | Alembic Pharmaceuticals Inc. | 96434354-a646-4869-92a2-4052d3f7a4aa | 2025-12-02 | Warnings, Adverse reactions | EH6D7113I8 |
| Clindamycin Phosphate | CLINDAMYCIN PHOSPHATE | Padagis Israel Pharmaceuticals Ltd | e492d645-7d2e-4f8a-a43a-9999456e9f72 | 2025-11-30 | Warnings, Adverse reactions | EH6D7113I8 |
| Clindamycin Phosphate | CLINDAMYCIN PHOSPHATE | A-S Medication Solutions | c205b9e8-3f62-4176-be4e-bc4b5dbf3893 | 2025-11-25 | Warnings, Adverse reactions | EH6D7113I8 |
| Cleocin T | CLINDAMYCIN PHOSPHATE | Pharmacia & Upjohn Company LLC | 4a3901a4-194f-4a15-9c85-3d0982afcf31 | 2025-11-24 | Warnings, Adverse reactions | EH6D7113I8 |
| Cleocin | CLINDAMYCIN PHOSPHATE | Pharmacia & Upjohn Company LLC | f9be442d-0782-4b93-828f-9ebbf67dbced | 2025-11-19 | Warnings, Adverse reactions | EH6D7113I8 |
| Clindamycin Phosphate | CLINDAMYCIN PHOSPHATE | A-S Medication Solutions | ba3f54e5-1ff5-4ffd-8ed2-f15439f423e9 | 2025-11-18 | Warnings, Adverse reactions | EH6D7113I8 |
| Clindamycin Phosphate | CLINDAMYCIN PHOSPHATE | Bryant Ranch Prepack | 654477df-5cbb-491a-8aec-651598b76884 | 2025-10-24 | Warnings, Adverse reactions | EH6D7113I8 |
| CLINDAMYCIN PHOSPHATE AND BENZOYL PEROXIDE CLINDAMYCIN PHOSPHATE AND BENZOYL PEROXIDE | CLINDAMYCIN PHOSPHATE AND BENZOYL PEROXIDE | Bryant Ranch Prepack | be216018-c30d-4184-9152-ae238e3edac4 | 2025-10-22 | Warnings, Adverse reactions | EH6D7113I8 |
| Clindamycin Phoaphate Topical Solution USP, 1% | CLINDAMYCIN PHOSPHATE TOPICAL SOLUTION USP, 1% | Encube Ethicals, Inc. | b2dfb76b-db09-43e7-8366-6791449a4918 | 2025-09-05 | Warnings, Adverse reactions | EH6D7113I8 |
| Clindamycin Phosphate | CLINDAMYCIN PHOSPHATE | Chartwell RX, LLC | 7740ed35-ff93-4c5e-8983-934ff7b86da7 | 2025-09-05 | Warnings, Adverse reactions | EH6D7113I8 |
| Clindamycin Phosphate and Tretinoin Gel 1.2%/0.025% | CLINDAMYCIN PHOSPHATE AND TRETINOIN GEL 1.2%/0.025% | Encube Ethicals, Inc. | 1f772408-52a3-45b2-b053-8fc78948983c | 2025-09-05 | Warnings, Adverse reactions | EH6D7113I8 |
| CLINDAMYCIN PHOSPHATE AND BENZOYL PEROXIDE CLINDAMYCIN PHOSPHATE AND BENZOYL PEROXIDE | CLINDAMYCIN PHOSPHATE AND BENZOYL PEROXIDE | Encube Ethicals, Inc. | 8ca01174-431e-449a-a85e-8c68d506776c | 2025-08-29 | Warnings, Adverse reactions | EH6D7113I8 |
| Clindamycin Phosphate and Benzoyl Peroxide | CLINDAMYCIN PHOSPHATE AND BENZOYL PEROXIDE | Oceanside Pharmaceuticals | 1d53ec2b-d33d-4245-99f1-e41b30303660 | 2025-08-15 | Warnings, Adverse reactions | EH6D7113I8 |
| ONEXTON | CLINDAMYCIN PHOSPHATE AND BENZOYL PEROXIDE | Bausch Health US, LLC | 697e760a-c206-4565-8f4e-a8085e215827 | 2025-07-23 | Warnings, Adverse reactions | EH6D7113I8 |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.